- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Drug development in Alzheimer’s disease: the path to 2025 ; volume:8 ; number:1 ; day:20 ; month:9 ; year:2016 ; pages:1-12 ; date:12.2016
Alzheimer's research & therapy ; 8, Heft 1 (20.9.2016), 1-12, 12.2016
- Urheber
- Beteiligte Personen und Organisationen
-
Aisen, Paul S.
Dubois, Bruno
Frölich, Lutz
Jack, Clifford R.
Jones, Roy W.
Morris, John C.
Raskin, Joel
Dowsett, Sherie A.
Scheltens, Philip
SpringerLink (Online service)
- DOI
-
10.1186/s13195-016-0207-9
- URN
-
urn:nbn:de:1111-201610152507
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cummings, Jeffrey L.
- Aisen, Paul S.
- Dubois, Bruno
- Frölich, Lutz
- Jack, Clifford R.
- Jones, Roy W.
- Morris, John C.
- Raskin, Joel
- Dowsett, Sherie A.
- Scheltens, Philip
- SpringerLink (Online service)
Ähnliche Objekte (12)
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
The “rights” of precision drug development for Alzheimer’s disease
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
On the path to 2025: understanding the Alzheimer’s disease continuum
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
The plasma peptides of Alzheimer’s disease
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Reproducibility of EEG functional connectivity in Alzheimer’s disease
Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study
Sensitive and reproducible MEG resting-state metrics of functional connectivity in Alzheimer’s disease
A multiscale brain network model links Alzheimer’s disease-mediated neuronal hyperactivity to large-scale oscillatory slowing
Considerations regarding a diagnosis of Alzheimer’s disease before dementia: a systematic review
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
The “rights” of precision drug development for Alzheimer’s disease
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
On the path to 2025: understanding the Alzheimer’s disease continuum
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
The plasma peptides of Alzheimer’s disease
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Reproducibility of EEG functional connectivity in Alzheimer’s disease
Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study
Sensitive and reproducible MEG resting-state metrics of functional connectivity in Alzheimer’s disease
A multiscale brain network model links Alzheimer’s disease-mediated neuronal hyperactivity to large-scale oscillatory slowing
Considerations regarding a diagnosis of Alzheimer’s disease before dementia: a systematic review
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
The “rights” of precision drug development for Alzheimer’s disease
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
On the path to 2025: understanding the Alzheimer’s disease continuum
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
The plasma peptides of Alzheimer’s disease
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Reproducibility of EEG functional connectivity in Alzheimer’s disease
Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study
Sensitive and reproducible MEG resting-state metrics of functional connectivity in Alzheimer’s disease
A multiscale brain network model links Alzheimer’s disease-mediated neuronal hyperactivity to large-scale oscillatory slowing